325 related articles for article (PubMed ID: 11146623)
1. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Mazumdar A; Wang RA; Mishra SK; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi RK; Kumar R
Nat Cell Biol; 2001 Jan; 3(1):30-7. PubMed ID: 11146623
[TBL] [Abstract][Full Text] [Related]
2. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
[TBL] [Abstract][Full Text] [Related]
3. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.
Khaleque MA; Bharti A; Gong J; Gray PJ; Sachdev V; Ciocca DR; Stati A; Fanelli M; Calderwood SK
Oncogene; 2008 Mar; 27(13):1886-93. PubMed ID: 17922035
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
Talukder AH; Gururaj A; Mishra SK; Vadlamudi RK; Kumar R
Mol Cell Biol; 2004 Aug; 24(15):6581-91. PubMed ID: 15254226
[TBL] [Abstract][Full Text] [Related]
5. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene.
Molli PR; Singh RR; Lee SW; Kumar R
Oncogene; 2008 Mar; 27(14):1971-80. PubMed ID: 17922032
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
7. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
8. MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.
Talukder AH; Mishra SK; Mandal M; Balasenthil S; Mehta S; Sahin AA; Barnes CJ; Kumar R
J Biol Chem; 2003 Mar; 278(13):11676-85. PubMed ID: 12527756
[TBL] [Abstract][Full Text] [Related]
9. Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator.
Ohshiro K; Rayala SK; Wigerup C; Pakala SB; Natha RS; Gururaj AE; Molli PR; Månsson SS; Ramezani A; Hawley RG; Landberg G; Lee NH; Kumar R
EMBO Rep; 2010 Sep; 11(9):691-7. PubMed ID: 20651739
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
Liu XF; Bagchi MK
J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
[TBL] [Abstract][Full Text] [Related]
11. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines.
Salot S; Gude R
Eur J Cancer; 2013 Jan; 49(2):492-9. PubMed ID: 22841502
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
13. MTA1, a transcriptional activator of breast cancer amplified sequence 3.
Gururaj AE; Singh RR; Rayala SK; Holm C; den Hollander P; Zhang H; Balasenthil S; Talukder AH; Landberg G; Kumar R
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6670-5. PubMed ID: 16617102
[TBL] [Abstract][Full Text] [Related]
14. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
Sharma D; Saxena NK; Davidson NE; Vertino PM
Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
[TBL] [Abstract][Full Text] [Related]
15. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
16. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of MTA family members in human cancers.
Kumar R; Wang RA; Bagheri-Yarmand R
Semin Oncol; 2003 Oct; 30(5 Suppl 16):30-7. PubMed ID: 14613024
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Singh RR; Barnes CJ; Talukder AH; Fuqua SA; Kumar R
Cancer Res; 2005 Nov; 65(22):10594-601. PubMed ID: 16288053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
